Tech Company Financing Transactions
Phenomix Funding Round
Phenomix, based in San Diego, scored $55 million in investment from Nomura Phase4 Ventures, Alta Partners and Baker Capital.
Transaction Overview
Company Name
Announced On
3/8/2007
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors
Nomura Phase4 Ventures (Lead Investor) (Denise Pollard-Knight)
Proceeds Purpose
The Series C financing will support continued clinical development of PHX1149 for the treatment of type 2 diabetes while also funding Phenomix' additional programs directed at the hepatitis C virus and other high-value therapeutic targets. PHX1149 is a once-daily DPP4 inhibitor for treatment of type 2 diabetes that will commence phase 2b clinical trials in Q2 2007.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
5930 Cornerstone Court West 230
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Phenomix is a drug discovery and development company building a therapeutic portfolio for treatment of immune disease and metabolic syndrome.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Shawver
Chief Medical Officer
Hans-Peter Guler
Vice President
Angela Birchler
Vice President
Marie O'Farrell
VP - Finance
Brian Baker
Browse more venture capital transactions:
Prev: 3/8/2007: SprayCool venture capital transaction
Next: 3/8/2007: Pixim venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs